Therapeutic Strategies in the Stages of COVID-19

Therapeutic Strategies in the Stages of COVID-19 

Paul Bergner 2020

150 minutes 2.5 CEU credit

This material was presented after clinical experiences during the first 3-month wave wave of COVID-19 in the USA and the UK. At the time COVID-19 was more severe, and also tended to progress in certain stages. Today, with near universal immunity in the population from immunization and/or previous exposure, the presentation is not usually as severe. This material may still give insights into prevention, assessment of risk, and therapeutics for respiratory infection We are offering this materia for insights into the treatment of various stages of COVID-19 presentation. We will describe risk factors for severe illness, historical research into the materia medica and formulations used by British herbalists during the 1918 influenza pandemic, and daily ongoing review of contemporary case reports from North America and the UK. We will describe an herbal strategy of adapting therapeutics to 5 stages of the illness: Prevention, Infection, "Tipping Point", Inflammation, and Recovery. 

Materials

• The audio lecture

• Lecture slides.

Related Continuing Education Lectures

• Treatment of Acute Febrile Illness

• The Antiviral Materia Medica

• The Antiviral Materia Medica Mechanisms and Actions

• Boneset and Pleurisy Root – History and Contemporary Uses

• Acute Viral Respiratory Infection - Prevention and Therapeutics

• Influenza Prevention and Therapeutics

Related courses

• Infectious Disease: Viral Infection

This lecture is offered as Continuing Education by the NAIMH, but has not been pre-approved for CE credits by any professional board.